Mobius Life Sciences
News & Events
Mobius Life Sciences' Investments
CompanDX holds the key to value generation in the exciting new field of Personalised Medicine....
XenoGesis Ltd. is a laboratory-based contract research organisation (CRO) specialised in preclinical drug metabolism &...
CellAura Technologies is the premier source of innovative fluorescent screening products for life science research...
Haemostatix is developing first-in-class clotting agents for the treatment of bleeding or ‘haemostasis’. The company...
BioCity Nottingham also invested in R5 Pharmaceuticals and the company was subsequently sold
© Mobius Life Sciences 2013
Web site design by